13318-97-3 Usage
Occurrence
Naturally occurring in certain marine organisms, including some species of sponges and bacteria
Classification
Acidic amino acid derivative
Research Interest
Studied for potential pharmaceutical and medicinal properties
Potential Applications
Investigated as a potential treatment for cancer and other diseases
Structure
Unique molecular structure drives further research into its properties and potential uses
Check Digit Verification of cas no
The CAS Registry Mumber 13318-97-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,1 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13318-97:
(7*1)+(6*3)+(5*3)+(4*1)+(3*8)+(2*9)+(1*7)=93
93 % 10 = 3
So 13318-97-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H12N2O2/c1-3(7-2)4(6)5(8)9/h3-4,7H,6H2,1-2H3,(H,8,9)
13318-97-3Relevant articles and documents
Stereochemical elucidation and total synthesis of dihydropacidamycin D, a semisynthetic pacidamycin
Boojamra,Lemoine,Lee,Leger,Stein,Vernier,Magon,Lomovskaya,Martin,Chamberland,Lee,Hecker,Lee
, p. 870 - 874 (2007/10/03)
Hydrogenation of the C(4′) exocyclic olefin of the pacidamycins has been shown to produce a series of semisynthetic compounds, the dihydropacidamycins, with antimicrobial activity similar to that of the natural products. Elucidation of stereochemistry in
Antibiotics napsamycins A-D, process for their production and their use as pharmaceuticals
-
, (2008/06/13)
This invention relates to new antibacterial antibiotics Napsamycins A - D of the formula Napsamycin A :R1 = H, R2 = uracil Napsamycin B :R1 = CH3, R2 = uracil Napsamycin C :R1 = H, R2 = dihydrouracil Napsamycin D :R1 = CH3, R2 = dihydrouracil from a strain of Streptomyces candidus, Y-82,11372 (DSM 5940).
